Literature DB >> 34531528

Biallelic null variants in ZNF142 cause global developmental delay with familial epilepsy and dysmorphic features.

Shinichi Kameyama1,2, Takeshi Mizuguchi1, Hiromi Fukuda1,3, Lip Hen Moey4, Wee Teik Keng5, Nobuhiko Okamoto6, Naomi Tsuchida1,7, Yuri Uchiyama1,7, Eriko Koshimizu1, Kohei Hamanaka1, Atsushi Fujita1, Satoko Miyatake1,8, Naomichi Matsumoto9.   

Abstract

Biallelic variants in ZNF142 at 2q35, which encodes zinc-finger protein 142, cause neurodevelopmental disorder with seizures or dystonia. We identified compound heterozygous null variants in ZNF142, NM_001105537.4:c.[1252C>T];[1274-2A>G],p.[Arg418*];[Glu426*], in Malaysian siblings suffering from global developmental delay with epilepsy and dysmorphism. cDNA analysis showed the marked reduction of ZNF142 transcript level through nonsense-mediated mRNA decay by these novel biallelic variants. The affected siblings present with global developmental delay and epilepsy in common, which were previously described, as well as dysmorphism, which was not recognized. It is important to collect patients with ZNF142 abnormality to define its phenotypic spectrum.
© 2021. The Author(s), under exclusive licence to The Japan Society of Human Genetics.

Entities:  

Mesh:

Year:  2021        PMID: 34531528     DOI: 10.1038/s10038-021-00978-y

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  2 in total

1.  Clinical course of a Japanese patient with developmental delay linked to a small 6q16.1 deletion.

Authors:  Tetsuya Okazaki; Tatsuya Kawaguchi; Yusuke Saiki; Chisako Aoki; Noriko Kasagi; Kaori Adachi; Ken Saida; Naomichi Matsumoto; Eiji Nanba; Yoshihiro Maegaki
Journal:  Hum Genome Var       Date:  2022-05-17

2.  Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder.

Authors:  Maria B Christensen; Amanda M Levy; Nazanin A Mohammadi; Marcello Niceta; Rauan Kaiyrzhanov; Maria Lisa Dentici; Chadi Al Alam; Viola Alesi; Valérie Benoit; Kailash P Bhatia; Tatjana Bierhals; Christian M Boßelmann; Julien Buratti; Bert Callewaert; Berten Ceulemans; Perrine Charles; Matthias De Wachter; Mohammadreza Dehghani; Erika D'haenens; Martine Doco-Fenzy; Michaela Geßner; Cyrielle Gobert; Ulviyya Guliyeva; Tobias B Haack; Trine B Hammer; Tilman Heinrich; Maja Hempel; Theresia Herget; Ute Hoffmann; Judit Horvath; Henry Houlden; Boris Keren; Christina Kresge; Candy Kumps; Damien Lederer; Alban Lermine; Francesca Magrinelli; Reza Maroofian; Mohammad Yahya Vahidi Mehrjardi; Mahdiyeh Moudi; Amelie J Müller; Anna J Oostra; Beth A Pletcher; David Ros-Pardo; Shanika Samarasekera; Marco Tartaglia; Kristof Van Schil; Julie Vogt; Evangeline Wassmer; Juliane Winkelmann; Maha S Zaki; Michael Zech; Holger Lerche; Francesca Clementina Radio; Paulino Gomez-Puertas; Rikke S Møller; Zeynep Tümer
Journal:  Clin Genet       Date:  2022-06-08       Impact factor: 4.296

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.